The debate about the control and possible elimination of covid-19 has focused on costs and harms versus benefits […]
Yamey and Walensky discuss some considerations for UK universities re-opening this academic year.1 This is important because rising […]
NHS trusts in England have reported various risks to the safety of patients linked to staffing shortages, lack […]
Drug is ready to progress into clinical trials after passing initial safety test
Investigational gene therapy was developed by professor Brian Bigger
Research tool will predict disease severity and therapeutic response
Two-drug regimen continues to offer non-inferior efficacy compared to a three-drug regimen
Updated Date: Mon, 28 Sep 2020 00:00:00 EDT
Updated Date: Mon, 28 Sep 2020 00:00:00 EDT
